A comparison of change point models with application to longitudinal lung function measurements in children with
Angela Moss1, E Juarez-Colunga1,2, Farouk Nathoo3
1Adult and Child Consortium for Health Outcomes and Delivery Science, University of Colorado Denver School of Medicine, Aurora, 80045, CO, U.S.A.
Insights
Cystic fibrosis (CF) patients show varied lung function decline rates. A mixed random change point model identified two adolescent subgroups: one with a slow 0.5% FEV1 decline and another with a rapid 4.4% FEV1 decline.
Area of Science:
- Pulmonology
- Biostatistics
- Pediatric Medicine
Background:
- Cystic fibrosis (CF) is a genetic disorder causing progressive lung function loss.
- Adolescence is a critical period for accelerated lung function decline in CF.
- A hypothesis suggests a subgroup of CF patients experiences a slower, more stable decline.
Purpose of the Study:
- To model lung function decline in pediatric and adolescent CF patients.
- To compare four distinct change point models for analyzing lung function trajectories.
- To identify distinct patient subgroups based on lung function decline patterns.
Main Methods:
- Utilized data from the University of Colorado CF Children's Registry.
- Investigated four change point models: mixture-random, mixture-fixed, random, and fixed.
- Employed posterior predictive simulation for individual and population-level analysis.
- Conducted a simulation study to assess model misspecification effects.
Main Results:
- The mixed random change point model was identified as the most suitable.
- Approximately 30% of adolescents exhibited a steady annual decline of 0.5% in FEV1.
- Roughly 70% of adolescents experienced an accelerated decline of 4.4% in FEV1 annually.
- This accelerated decline began around the average age of 14.6 years.
Conclusions:
- The mixed random change point model effectively captures heterogeneous lung function decline in CF adolescents.
- Identified two distinct trajectories of lung function decline, highlighting personalized disease progression.
- Findings underscore the importance of age-specific monitoring and intervention strategies in CF care.
Abstract:
Cystic fibrosis (CF) is a hereditary lung disease characterized by loss of lung function over time. Lung function in CF is believed to decline at a higher rate during the adolescence period. It has been also hypothesized that there is a subgroup of individuals for whom lung disease remains relatively stable with only a slight decline over their lifetime. Using data from the University of Colorado CF Children's Registry, we investigate four change point models to model the decline of lung function in children and adolescents: (i) a two-component mixture random change point model, (ii) a two-component mixture-fixed change point model, (iii) a random change point model, and (iv) a fixed change point model. The models are investigated through posterior predictive simulation at the individual and population levels, and a simulation study examining the effects of model misspecification. The data support the mixed random change point model as the preferred model, with roughly 30% of adolescents experiencing a steady decline of 0.5 %FEV1 per year and 70% experiencing an increase in decline of 4.4 %FEV1 per year beginning on average at 14.6 years of age. Copyright © 2016 John Wiley & Sons, Ltd.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Longitudinal Research
Longitudinal Studies
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History


